Friday, October 12, 2007 1:09:21 PM
There are NO OTHER therapy types in the DNAG pipeline. NONE.
Oh, and meanwhile, 160,000 people a year are dying from "old drug" reactions.
That is certainly true and certainly part of the sales pitch. But there is not one product in the pipeline that addresses that fact. Not one.
To try and and insinuate that DNAPrint just wants to take old drugs and enhance them is shortsighted and deceptive.
It's all they have ever tried to do. It is all they have ever failed to do. All contrary hype aside.
regards,
frog
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM